About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.